Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer

Molecular and Cellular Biochemistry

Volumn 380, Issue 1-2, 2013, Pages 177-184

  Xue, Baoyao ^a   Wu, Weiguang ^b   Huang, Kan ^a   Xie, Tingting ^a   Xu, Xiaobo ^a   Zhang, Hongju ^a   Qi, Chunlei ^a   Ge, Junli ^a   Yu, Yuecheng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Affiliated Hospital of Logistics College of Chinese Peoples Armed Police Force   (China)

Author keywords

v 6 integrin; CXCR4; Invasion; Ovarian cancer; SDF 1

Indexed keywords

ALPHAVBETA6 INTEGRIN; CHEMOKINE RECEPTOR CXCR4; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL INVASION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; OVARY CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR INVASION; UPREGULATION;

ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROCYCLIC COMPOUNDS; HUMANS; IMIDAZOLES; INTEGRINS; MORPHOLINES; OVARIAN NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PYRIDINES; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME FACTORS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84879796776     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1671-1     Document Type: Article

References (31)

1. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (New York, NY) 244(4905):707
2. Naora H, Montell DJ (2005) Ovarian cancer metastasis: integrating insights from disparate model organisms. Mol Cell Biochem 5(5):355-366
3. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52-67
4. Guo W, Giancotti FG (2004) Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5(10):816-826
5. Arihiro K, Kaneko M, Fujii S, Inai K, Yokosaki Y (2000) Significance of α9β1 and αvβ6 integrin expression in breast carcinoma. Breast Cancer 7(1):19-26
6. Yue J, Zhang K, Chen JF (2012) Role of integrins in regulating proteases to mediate extracellular matrix remodeling. Cancer Microenviron 5(3):1-9
7. Hezel AF, Deshpande V, Zimmerman SM, Contino G, Alagesan B, O'Dell MR, Rivera LB, Harper J, Lonning S, Brekken RA (2012) TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression. Cancer Res 72(18):4840-4845
8. Yang SB, Du Y, Wu BY, Xu SP, Wen JB, Zhu M, Cai CH, Yang PC (2012) Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer. Cancer Immunol Immunother 61(3):335-342
9. Eberlein C, Kendrew J, McDaid K, Alfred A, Kang J, Jacobs V, Ross S, Rooney C, Smith N, Rinkenberger J (2012) A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo. Oncogene
10. Thomas GJ, Poomsawat S, Lewis MP, Hart IR, Speight PM, Marshall JF (2001) αvβ6 integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. J Invest Dermatol 116(6):898-904
11. Hazelbag S, Kenter G, Gorter A, Dreef E, Koopman L, Violette S, Weinreb P, Fleuren G (2007) Overexpression of the αvβ6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival. J Pathol 212(3):316-324
12. Bandyopadhyay A, Raghavan S (2009) Defining the role of integrin αvβ6 in cancer. Curr Drug Targets 10(7):645
13. Teicher BA, Fricker SP (2010) CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 16(11):2927-2931
14. Righi E, Kashiwagi S, Yuan J, Santosuosso M, Leblanc P, Ingraham R, Forbes B, Edelblute B, Collette B, Xing D (2011) CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer. Cancer Res 71(16):5522-5534
15. Gillette JM, Larochelle A, Dunbar CE, Lippincott-Schwartz J (2009) Intercellular transfer to signalling endosomes regulates an ex vivo bone marrow niche. Nat Cell Biol 11(3):303-311
16. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM (2003) The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167(12):1676-1686
17. Liang Z, Wu T, Lou H, Yu X, Taichman RS, Lau SK, Nie S, Umbreit J, Shim H (2004) Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 64(12):4302-4308
18. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50-56
19. Sun YX, Fang M, Wang J, Cooper CR, Pienta KJ, Taichman RS (2006) Expression and activation of αvβ3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells. Prostate 67(1):61-73
20. Kryczek I, Wei S, Keller E, Liu R, Zou W (2007) Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 292(3):C987-C995
21. Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, Bridger G, Balkwill FR (2002) Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 62(20):5930-5938
22. Yuecheng Y, Xiaoyan X (2007) Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2. Eur J Cancer Prev 16(5):430-435
23. Benasciutti E, Pagès G, Kenzior O, Folk W, Blasi F, Crippa MP (2004) MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription. Blood 104(1):256-262
24. Xu MY, Porte J, Knox AJ, Weinreb PH, Maher TM, Violette SM, McAnulty RJ, Sheppard D, Jenkins G (2009) Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). Am J Pathol 174(4):1264-1279
25. Lakka SS, Jasti SL, Gondi C, Boyd D, Chandrasekar N, Dinh DH, Olivero WC, Gujrati M, Rao JS (2002) Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene 21(36):5601-5608
26. Thomas G, Nyström M, Marshall J (2006) αvβ6 integrin in wound healing and cancer of the oral cavity. J Oral Pathol Med 35(1):1-10
27. Stewart DA, Cooper CR, Sikes RA (2004) Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer. Reprod Biol Endocrinol 2(2):1-13
28. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold MET, Sunshine MJ, Littman DR, Kuo CJ (2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203(9):2201-2213
29. Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285(5430):1028-1033
30. Wiseman BS, Werb Z (2002) Stromal effects on mammary gland development and breast cancer. Science 296(5570):1046-1049
31. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat Rev Cancer 2(7):489-501